RR

Rajesh Ranjan

Director Managing Director DIN 01567924
DIN 01567924 First appointment Sep 1990
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 1990
Shareholding value •••• Premium profile

About Rajesh Ranjan

Data last updated:

Rajesh Ranjan was a Managing Director at Ranjan Pharma Private Limited (1990–2010) and Director at Kemphar Laboratories Limited (1995–2010).

DIN 01567924
Primary Designation Managing Director
First Appointment 17 Sep 1990

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ranjan Pharma Private Limited U00064BR1990PTC004166
Managing Director17 Sep 19901990Active
Kemphar Laboratories Limited U00304BR1989PLC003590
Director14 Jan 19951989Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ranjan Pharma Private Limited
Kemphar Laboratories Limited
Premium access

Shareholding and investment profile for Rajesh Ranjan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajesh Ranjan

Rajesh Ranjan was first appointed on 17 Sep 1990 as Managing Director at Ranjan Pharma Private Limited. The most recent appointment on record is 14 Jan 1995 at Kemphar Laboratories Limited.

Rajesh Ranjan held 2 earlier board appointments: Ranjan Pharma Private Limited (Managing Director, 17 Sep 1990 to 13 May 2010); Kemphar Laboratories Limited (Director, 14 Jan 1995 to 13 May 2010).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available